It’s an understandable question: If human embryonic stem cells can be produced by “reprogramming” the genes in a person’s skin cells, then why continue to pursue research involving stem cells that come from human embryos that must be destroyed in order to gather them?...
Attorney Joe Hildebrandt has been a part of many deals connecting promising young Wisconsin companies with investors, some close at home and others in the financial centers of the nation’s East and West Coasts. ...
You can always tell when a DEMO conference is just a few weeks away because I begin to sort and organize and otherwise occupy my time with activities other than writing program notes and working on opening remarks. I like to think that my ideas...
The real question is not evolution versus intelligent design, but whether this debate is worth more than a nanosecond of public effort? Given the more urgent challenges in science education today, it would be far more useful if the president turned his attention to America's...
The Midwest is well poised to not only maintain its historic leadership in medical diagnostics, but increase that leadership so long as it takes advantage of some of the newer emerging technologies and companies....
Today it's the direct form that rules, the manufacturer's product going straight to the lap of the end user. No matter if the end user is a teenager, a roofer or a big business, a single-item purchase is sufficient....
There are many reasons why space exploration, still dangerous and costly, is worth the risk. One of the biggest reasons is also the most intangible, and sometimes the hardest to explain to those who wonder why we want to revisit the moon or travel to...
Last week, we talked about the size and growth of the medical device industry and some of the key market segments. This week's column will focus on the leading players in this $100 billion industry....
If there is a big theme for DEMOfall, it is a move toward simplicity, whether we’re talking about consumer Web services or enterprise applications and IT management, the coming wave of innovation is all about making our lives easier....
Wisconsin companies regularly and eagerly await responses from the FDA to requests for authorization of clinical trials, submissions for premarket clearance, and other submissions and applications. But a different type of FDA letter -- a warning letter -- is much less welcome....